Patents by Inventor Timothy J. McDermott

Timothy J. McDermott has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150230764
    Abstract: A dose-reducing x-ray aiming device includes an aiming ring having shield with an aperture, at least one arm, and at least one sensor holder. The dose-reducing x-ray aiming ring is generally used to aim a dental x-ray machine and at least partially shield some of the x-rays emitted from the x-ray machine while capturing radiographs. X-rays generally pass through the aperture and then interact with a sensor for capturing the radiographs after passing through the tissue of a patient. In one embodiment, the x-ray aiming device provides an all-in-one aiming ring, which allows a user to capture both periapical and bitewing radiographs with a single device. The aiming device also includes an annular ridge or lip which helps align the x-ray machine with the aiming device.
    Type: Application
    Filed: February 19, 2014
    Publication date: August 20, 2015
    Inventors: Jeremy Charnegie, Timothy J. McDermott, Lisa A. Ratnow, Joseph J. Bria, III, Carl A. Yacono, Adam T. Palermo
  • Patent number: 7897175
    Abstract: A dosage form comprises (1) a solid amorphous dispersion comprising a cholesterol ester transfer protein inhibitor and an acidic concentration-enhancing polymer and (2) an HMG-CoA reductase inhibitor. The solid amorphous dispersion and the HMG-CoA reductase inhibitor are combined in the dosage form so that the solid amorphous dispersion and the HMG-CoA reductase inhibitor are substantially separate from one another in the dosage form.
    Type: Grant
    Filed: December 18, 2003
    Date of Patent: March 1, 2011
    Assignee: Bend Research, Inc.
    Inventors: Dwayne T. Friesen, David K. Lyon, Douglas A. Lorenz, Bruno C. Hancock, Timothy J. McDermott, Ravi M. Shanker
  • Publication number: 20040197398
    Abstract: A dosage form comprises (1) a solid amorphous dispersion comprising a cholesterol ester transfer protein inhibitor and an acidic concentration-enhancing polymer and (2) an HMG-CoA reductase inhibitor. The solid amorphous dispersion and the HMG-CoA reductase inhibitor are combined in the dosage form so that the solid amorphous dispersion and the HMG-CoA reductase inhibitor are substantially separate from one another in the dosage form.
    Type: Application
    Filed: December 18, 2003
    Publication date: October 7, 2004
    Applicant: Pfizer Inc.
    Inventors: Dwayne T. Friesen, David K. Lyon, Douglas A. Lorenz, Bruno C. Hancock, Timothy J. McDermott, Ravi M. Shanker
  • Publication number: 20040185102
    Abstract: A dosage form comprises (1) a solid amorphous dispersion comprising a cholesteryl ester transfer protein inhibitor and a neutral or neutralized acidic polymer and (2) an HMG-CoA reductase inhibitor. The dosage form provides improved chemical stability of the HMG-CoA reductase inhibitor.
    Type: Application
    Filed: December 18, 2003
    Publication date: September 23, 2004
    Applicant: Pfizer Inc
    Inventors: Dwayne T. Friesen, David K. Lyon, Douglas A. Lorenz, Rodney J. Ketner, Bruno C. Hancock, Timothy J. McDermott, Ravi M. Shanker
  • Patent number: D828577
    Type: Grant
    Filed: February 12, 2016
    Date of Patent: September 11, 2018
    Assignee: DENTAL IMAGING TECHNOLOGIES CORPORATION
    Inventors: Jeremy Charnegie, Timothy J. McDermott, Lisa A. Ratnow, Joseph J. Bria, Carl A. Yacono, Adam T. Palermo